Sign in
Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
Journal article   Open access  Peer reviewed

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

Nikoletta Lendvai, Ioanna Tsakos, Sean M Devlin, Wendy L Schaffer, Hani Hassoun, Alexander M Lesokhin, Heather Landau, Neha Korde, Sham Mailankody, Eric Smith, …
Leukemia & lymphoma, Vol.59(8), pp.1981-1985
2018-08
PMID: 29308691

Abstract

Aged Aged, 80 and over Biomarkers, Tumor - analysis Cardiotoxicity - diagnosis Cardiotoxicity - physiopathology Cardiotoxicity - prevention & control Female Heart Diseases - chemically induced Heart Diseases - diagnosis Heart Diseases - physiopathology Humans Male Middle Aged Multiple Myeloma - drug therapy Oligopeptides - adverse effects Oligopeptides - therapeutic use Practice Guidelines as Topic Predictive Value of Tests Proteasome Inhibitors - adverse effects Proteasome Inhibitors - therapeutic use
url
https://doi.org/10.1080/10428194.2017.1403020View
Published (Version of record) Open

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.130 Lymphomas
1.130.617 Multiple Myeloma
Web Of Science research areas
Hematology
Oncology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details